期刊文献+

瘦素对乳腺癌MCF-7细胞增殖的影响及调控机制的研究 被引量:10

Effects of leptin on breast cancer MCF-7 cells proliferation in vitro by regulation of estrogen receptor and VEGF
下载PDF
导出
摘要 目的:研究瘦素对人乳腺癌MCF-7细胞增殖的影响及对雌、孕激素受体和VEGF的mRNA表达水平的影响,进而揭示瘦素对乳腺癌MCF-7细胞系作用的分子生物学机制。方法:体外培养人乳腺癌MCF-7细胞系,分为对照组、瘦素组和雌激素组。给药后用MTT法测570nm分光光度值。实时荧光定量PCR法观察各组雌、孕激素受体及VEGF的mRNA表达水平。结果:与对照组相比,瘦素可以呈时间和剂量依赖的方式促进MCF-7细胞增殖,并上调细胞中雌、孕激素受体及VEGF的mRNA表达水平,P<0.05。结论:瘦素有促进乳腺癌细胞增殖的作用,该作用的发挥可能与其上调雌、孕激素受体与VEGF的表达有关。为乳腺癌的内分泌治疗提供了新的理论依据。 OBJECTIVE: To observe the proliferation of MCF-7 cells and the mRNA expression of estrogen receptor (ER), progesterone receptor (PGR) and VEGF after giving different concentrations of leptin or estrogen to MCF-7 cells, and to reveal the molecular biological mechanism of the effect of leptin on ER positive breast cancer cells. METHODS: After the culture of MCF-7 cells for 72 h in vitro, the cells were treated with leptin, estrogen or vehicle as control. After the medication, the 570 nm OD values of cells were read by MTT and the mRNA expressions of ER, PGR, and VEGF were observed with real-time PCR. RESULTS: Compared with the control group, leptin promoted the proliferation of MCF-7 cells in a dose and time dependent manner, and increased the mRNA expressions of ER, PGR, and VEGF, significantly ( P 〈 0.05). CONCLUSIONS: Leptin promotes breast cancer cells proliferation, and probably up-regular especially VEGF, This find for breast cancer endocrinot the mRNA expressions of ER, PGR, and ing may provide a new theoretical basis herapy.
出处 《中华肿瘤防治杂志》 CAS 2007年第24期1857-1859,共3页 Chinese Journal of Cancer Prevention and Treatment
基金 首都医学发展科研基金(2005-2031) 首都医科大学基础-临床科研合作基金(12260133)
关键词 乳腺肿瘤 瘦素 雌激素受体 孕激素受体 VEGF reast cancer leptin estrogen receptor progesterone receptor VEGF
  • 相关文献

参考文献10

  • 1Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue[J]. Nature, 1994, 372(6505) :425- 432.
  • 2Caro J F, Sinha M K, Kolaczynski J W, et al. Leptin: the tale of an obesity gene[J].Diabetes, 1996,45(11):1455- 462.
  • 3Rose D P, Gilhooly E M, Nixon D W. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin[J]. Int J Oncol, 2002,21(6):1285 -1292.
  • 4Deroo B J, Korach K S. Estrogen receptors and human disease[J]. J Clin Invest,2006,116(3):561-570.
  • 5Cleary M P, Maihle N J. The rule of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer[J]. Proc Soc Exp Biol Med, 1997, 216(1):28- 43.
  • 6Laud K, Gourdou I, Pessemesse L, et al. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line[J]. Mol Cell Endocrinol,2002,188(1-2):219- 226.
  • 7Garofalo C, Koda M, Cascio S, et al. Increasesd expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli[J]. Clin Cancer Res,2006,12(5):1447- 1453.
  • 8Catalano S, Mauro L, Marsico S, et al. Leptin induces, via ERK1/ ERK2 signal, functional activation of estrogen receptorain MCF-7 cells[J].J Biol Chem, 2004,279(19) :19908-19915.
  • 9Podarand K, Anderson K C. The pathophysiologic role of VEGF in hematologic malignancies: Therapeutic implications[J]. Blood, 2005,105(4):1383- 1395.
  • 10Gonzalez R R, Cherfils S, Escobar M, et al. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2)[J]. J Biol Chem, 2006, 281 (36): 26320 -26328.

同被引文献129

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部